CP Sports Infusion” (Glutathione: 2g/50ml)

CP Sports Infusion” (Glutathione: 2g/50ml)

Other ingredients: [Thiamine: 260mg/50ml; Riboflavin: 2mg/50ml; Nicotinamide: 100mg/50ml; Pyridoxine: 5mg/50ml; D- Panthenonate: 5mg/50ml;

Magnesium: 1g/ 50ml and Methylcobalamin: 250ug/50ml]

                                 Company name & Address                           registration number                   Batch number                         Expiry date  

Pack size

                                                               First distributed  

Re-call Classification

 

Recall date

 

Compounding Pharmacy of South Africa (CPSA). 2 Eaton Avenue,
cnr. Bryanston Drive, Bryanston, Johannesburg, 2121,
South Africa.

 

N/A (product by compounding pharmacy)

IV44762;

 

IV44821;

 

IV44830;

 

IV44856

 

IV44762:
04-11-2022;

IV44821:
09-11-2022;

IV44830:
10-11-2022;

IV44856
11-11-2022

 

50ml injectable vial

IV44762: 05-10-2022;
IV44821: 10-10-2022;
IV44830: 11-10-2022;
IV44856: 12-10-2022 
 

Class I Type C

 

 

21 Oct
2022

 

Reason for recall

The recall is due to reports of patients that have reacted to IV medicines, compounded by CPSA, and issued on prescription to medical practices. The medical practitioners of these patients communicated the information to the Compounding Pharmacy (the recall was initiated after the company (CPSA) was notified of patients being hospitalized). Details of complaints:                                                                                                                                   1 complaint: Nausea, vomiting, body aches, tachycardia, muscle weakness, headaches & shivers.
35 Complaints: Nausea, vomiting, body aches, tachycardia, muscle weakness, headaches & shivers.

 

Advice to HCPs/Distributors/Public:

The company requested their clients to refrain from dispensing the affected batches. An urgent notification (letter) was sent to all practices that received IVs containing the affected batches, as well as additional batches as a precautionary measure with immediate effect.

 

Proposed action taken and its urgency: A SAHPRA approved recall letter was distributed to all clients and recall initiated.

distributed to all distribution points and recall initiated.

 

Reporting side effects

Public and healthcare professionals are encouraged to report any side effects after using a health product or after immunisation by using the Med Safety App. Your report will contribute to our monitoring of these health products.

Download latest version
Version: 1
Date Updated: 21/10/2022
File Type: www
Category: Product Recall
Unit: General ECTD & human medicines, Regulatory Compliance